Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis
Open Access
- 15 December 2015
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 15 (1) , 1-9
Abstract
Non-alcoholic steatohepatitis (NASH) is often seen together with components of metabolic syndrome. The aim of this study was to assess the risk of de novo post-transplant type 2 diabetes (DM) in liver transplant recipients with NASH. All adult patients from the Scientific Registry of Transplant Recipients (2003–2012) transplanted for NASH or cryptogenic cirrhosis (the NASH cohort) without pre-transplant DM were included in this retrospective cross-sectional study. Total 2,916 NASH subjects and 14,268 controls with non-HCV related cirrhosis or hepatocellular carcinoma were included. Patients with NASH were, on average, 6 years older, more likely female and overweight/obese. By 5 years post-transplant, 39.8 % NASH vs. 27.0 % controls developed at least one onset of de novo DM; this was observed starting 6 months post-transplant: 22.9 % vs. 16.7 % (relative risk 1.38). Later in follow-up, the relative risk of de novo DM was also higher in NASH: 1.46 by 3 years, 1.47 by 5 years (all p < 0.0001). After exclusion of DM that resolved after the first year, long-term DM remained higher in the NASH cohort: 7.6 % vs. 4.3 %, p < 0.0001. In multivariate analysis, after adjustment for confounders including the use of immunosuppressants, having NASH was independently associated with development of de novo post-transplant DM: adjusted hazard ratio (95 % CI) = 1.29 (1.18–1.42), p < 0.0001. Liver transplant recipients with NASH have a higher risk of de novo post-transplant DM. This suggests the presence of an underlying metabolic disorder beyond fatty liver that may be causative for both NASH and type 2 diabetes.Keywords
This publication has 35 references indexed in Scilit:
- Metabolic and cardiovascular complications in the liver transplant recipient2015
- Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United StatesGastroenterology, 2015
- The outcomes of adult liver transplants in the United States from 1987 to 2013Liver International, 2015
- Recurrence of Disease After Liver TransplantationTransplantation Proceedings, 2013
- Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic ReviewClinical Gastroenterology and Hepatology, 2012
- Manifestations of Chronic Hepatitis C Virus Infection Beyond the LiverClinical Gastroenterology and Hepatology, 2010
- Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based studyGut, 2010
- Nonalcoholic fatty liver disease: A manifestation of the metabolic syndromeCleveland Clinic Journal of Medicine, 2008
- Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control studyHepatology, 2000
- Metabolic effects of liver transplantation in cirrhotic patients.Journal of Clinical Investigation, 1997